ReviewEuropean respiratory review : an official journal of the European Respiratory Society2017
The lung in amyloidosis.
Review in European respiratory review : an official journal of the European Respiratory Society, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 95 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
95 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Diffuse parenchymal pulmonary amyloidosis associated with multiple myeloma: a case report and systematic review of the literature.BMC cancer · 2018Pooled it
- Localized Tracheobronchial Transthyretin Amyloidosis Diagnosed After Hemoptysis: A Case Report.Respirology case reports · 2026Article
- Beyond the Biopsy: Diagnosing Pleural Amyloidosis Through Fluid Cytology.Diagnostic cytopathology · 2026Article
- Pulmonary Amyloidosis Diagnosed by Transbronchial Lung Biopsy: A Three-Case Series With Diverse Radiological Manifestations.Respirology case reports · 2026Article
- Cystic pulmonary amyloidosis with lymphoid interstitial pneumonia in Sjögren's disease: a case report.BMC pulmonary medicine · 2026Article
- Association Between Severe Aortic Stenosis and Amyloid Deposition in the Myocardium of Patients With Wild-Type Transthyretin Cardiac Amyloidosis.Circulation reports · 2026Article
- Pulmonary amyloidosis: clinicopathologic spectrum and diagnostic pitfalls in a 12-patient case series.Journal of thoracic disease · 2026Article
- Article
- Article
- Pulmonary coexistence of immunoglobulin light chain amyloidosis and light chain deposition disease: A case report.Respiratory medicine case reports · 2026Article
- Low-temperature plasma radiofrequency ablation combined with multimodal bronchoscopic interventions for tracheobronchial amyloidosis-induced airway stenosis: a case report and literature review.Frontiers in medicine · 2026Article
- Neutrophil Extracellular Traps Mediate in vitro and in vivo Degradation of α-Synuclein Amyloid Fibrils.Journal of inflammation research · 2026Article
- Nodular pulmonary amyloidosis presenting as a localized manifestation of lymphoproliferative disease: A three-case series.Respiratory medicine case reports · 2026Article
- Morphological Diversity and Diagnostic Evaluation of Thoracic Amyloidosis: Insights From a Tertiary Referral Center in Vietnam.Pulmonary medicine · 2026Article
- Pulmonary calcified nodules and cysts as the initial presentation of Sjögren's syndrome secondary nodular pulmonary amyloidosis: a rare case report.BMC pulmonary medicine · 2025Article
- The Great Mimicker, a Rare Pleural Presentation.CHEST pulmonary · 2025Article
- Article
- 60-Year-Old Man With Recurrent Hemoptysis, Pulmonary Nodules, and Mediastinal Lymphadenopathy.CHEST pulmonary · 2025Article
- Dyspnea and Right-Sided Heart Failure in a Patient With a History of Pneumonectomy.CHEST pulmonary · 2025Article
- Diffuse lung involvement as a rare presentation of systemic AL amyloidosis: a retrospective cohort study.Blood advances · 2025Article
35 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Amyloidosis is a disorder caused by misfolding of autologous protein and its extracellular deposition as fibrils, resulting in vital organ dysfunction and eventually death. Pulmonary amyloidosis may be localised or part of systemic amyloidosis.Pulmonary interstitial amyloidosis is symptomatic only if the amyloid deposits severely affect gas exchange alveolar structure, thus resulting in serious respiratory impairment. Localised parenchymal involvement may be present as nodular amyloidosis or as amyloid deposits associated with localised lymphomas. Finally, tracheobronchial amyloidosis, which is usually not associated with evident clonal proliferation, may result in airway stenosis.Because the treatment options for amyloidosis are dependent on the fibril protein type, the workup of all new cases should include accurate determination of the amyloid protein. Most cases are asymptomatic and need only a careful follow-up. Diffuse alveolar-septal amyloidosis is treated according to the underlying systemic amyloidosis. Nodular pulmonary amyloidosis is usually localised, conservative excision is usually curative and the long-term prognosis is excellent. Tracheobronchial amyloidosis is usually treated with bronchoscopic interventions or external beam radiation therapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.